Impaired neonatal macrophage phagocytosis is not explained by overproduction of prostaglandin E2

Megan N Ballinger1, Marc Peters-Golden, Bethany B Moore

  • 1Department of Internal Medicine, Division of Pulmonary and Critical Care Medicine, The University of Michigan, Ann Arbor, MI, USA. mnhender@umich.edu

Respiratory Research
|December 7, 2011
PubMed
Abstract

Insights

Neonatal rats have impaired alveolar macrophage (AM) function, producing more prostaglandin E(2) and less leukotriene B(4). This skewed eicosanoid profile does not explain the defective phagocytosis observed in young AMs.

Area of Science:

  • Immunology
  • Neonatal Research
  • Macrophage Biology

Background:

  • Neonates are highly susceptible to lung infections.
  • Eicosanoids play a role in macrophage-mediated host defense.
  • This study compares neonatal and adult rat alveolar macrophage (AM) function and lipid mediator production.

Purpose of the Study:

  • To investigate the relationship between AM host defense and lipid mediator production in neonatal versus adult rats.
  • To determine the functional capacity of neonatal AMs compared to adult AMs.

Main Methods:

  • Harvested AMs from young (day 7, 14) and adult (~10 week) rats.
  • Assessed phagocytosis, cytokine production, eicosanoid and cAMP levels via enzyme immunoassays.
  • Measured gene expression of proteins, enzymes, and receptors using real-time RT-PCR.

Main Results:

  • Young AMs showed defective phagocytosis and lower TNF-α production.
  • Young AMs produced more PGE(2) (host defense suppressor) and less LTB(4) (host defense promoter).
  • Defective phagocytosis was linked to decreased Fcgamma receptor gene expression in young AMs, not eicosanoid imbalance.

Conclusions:

  • Elevated PGE(2) and decreased LTB(4) do not cause impaired phagocytosis in young AMs.
  • Significant differences exist in young versus adult AM host defense mechanisms.
  • Fcgamma receptor expression is a key factor in neonatal AM phagocytic deficiency.